Nicox S.A. (OTCMKTS:NICXF) Short Interest Update

Nicox S.A. (OTCMKTS:NICXF) was the target of a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 100 shares, a decline of 83.3% from the May 15th total of 600 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 1.0 days.

Nicox Price Performance

Shares of NICXF stock opened at $0.25 on Friday. The company’s fifty day simple moving average is $0.25 and its two-hundred day simple moving average is $0.25. Nicox has a 1 year low of $0.25 and a 1 year high of $0.28.

Nicox Company Profile

Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.